Stereotactic body radiation therapy (SBRT)

In one sentence

Stereotactic body radiation therapy (SBRT) delivers a high dose per fraction to a defined target outside the brain using precise positioning, imaging and a small number of treatments.

The intuition

Think of concentrating a treatment into a tightly planned volume. That concentration creates two linked demands: reach the intended target reliably and control the dose to nearby tissues. A short course depends on extensive preparation. The number of treatment visits is only the visible part of the work.

How it works

Stereotactic body radiation therapy (SBRT) is a form of external-beam radiation. “Stereotactic” refers to locating the target in three-dimensional space and reproducing the treatment geometry. The related name stereotactic ablative radiotherapy (SABR) emphasizes the intended destructive dose. Neither name means a probe is inserted or tissue is removed.

Planning defines the target and nearby organs, models the dose, and accounts for uncertainty. During treatment, immobilization and imaging help reproduce the planned position. For moving targets, such as a lesion affected by breathing, motion assessment and a chosen management method are important parts of the plan. A small positioning error can matter when the dose changes rapidly near a critical structure.

Precision describes how exposure is controlled; follow-up is still needed to establish control and safety.

A fraction is one radiation treatment dose. SBRT usually concentrates treatment into a few fractions with a higher dose per fraction than a conventional course. Exact numbers, spacing and total dose depend on the treated organ, target location, disease setting and protocol. There is no single SBRT dose or universal lesion-size cutoff.

The target receives the intended high dose, but nearby tissues receive some exposure too. A steep falloff is useful only if the target is correctly located and organ limits are respected. Prior radiation, overlapping dose, lesion motion and closeness to sensitive structures can change feasibility. The ASTRO safety guidance treats specialized planning, delivery and quality checks as central requirements.

Why it matters in cancer

SBRT can provide local control in selected clinical settings. A prospective early lung-cancer study evaluated medically inoperable patients with defined peripheral tumors and measured both control and toxicity. That population and target geometry are part of its evidence. Results cannot be transferred automatically to a central lung lesion, another organ or a different cancer.

Other studies test SBRT in more limited metastatic patterns or alongside systemic treatment. Those are separate evidence questions. A strong local effect does not establish longer survival or an abscopal response. An “ablative” label does not establish a clinically optimal immune-priming schedule.

How it is measured

Planning evaluates target coverage and doses to nearby organs. Delivery checks evaluate positioning, motion and machine output. Later imaging and clinical follow-up evaluate control and adverse effects. A report should name the organ, site, disease setting, total dose and fractionation before comparing outcomes.

Worked example and practice

A fictional report says a liver lesion remained controlled after SBRT. It gives no information about disease elsewhere. Can its conclusion be “the treatment controlled the cancer throughout the body”?

Answer: The report supports treated-site control for the observed period. Systemic control requires information about other sites and follow-up. A local result should retain its local scope.

Common confusions

SBRT uses hypofractionation, but a hypofractionated course does not automatically use stereotactic positioning and delivery.
Stereotactic radiosurgery is the related term commonly used for brain targets; despite its name, it is radiation rather than an operation.
“Precise” does not mean zero normal-tissue dose or zero toxicity.
“Ablative” intent does not guarantee that every cancer cell is destroyed.

Explain it back

“SBRT concentrates radiation in a few treatments, so accurate geometry and nearby-organ limits are essential.”

Sources and scope

Source check: October 9, 2026. Delivery principles and evidence interpretation; doses, indications and safety depend on the actual setting. Expert and learner review remain pending.